MARKET

SCNX

SCNX

Scienture Holdings, Inc
NASDAQ
0.3701
+0.0371
+11.14%
After Hours: 0.3415 -0.0286 -7.73% 19:59 07/10 EDT
OPEN
0.3520
PREV CLOSE
0.3330
HIGH
0.3850
LOW
0.3350
VOLUME
46.71M
TURNOVER
--
52 WEEK HIGH
2.600
52 WEEK LOW
0.2382
MARKET CAP
15.04M
P/E (TTM)
-0.1636
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)
TipRanks · 20h ago
Why WD-40 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why
Benzinga · 1d ago
Scienture Announces Commercial Inventory Readiness For REZENOPY Naloxone Nasal Spray; Stock Up
NASDAQ · 1d ago
Scienture to begin shipments of Rezonopy to wholesalers
TipRanks · 1d ago
Scienture To Begin Shiptments Of REZENOPY Nasal Spray 10mg To U.S. Pharmaceutical Wholesalers Later This Month
Benzinga · 1d ago
SCIENTURE HOLDINGS - TO BEGIN JULY SHIPMENTS OF REZENOPY NASAL SPRAY 10 MG TO U.S. WHOLESALERS
Reuters · 1d ago
Weekly Report: what happened at SCNX last week (0629-0703)?
Weekly Report · 5d ago
More
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Webull offers Scienture Holdings Inc stock information, including NASDAQ: SCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNX stock methods without spending real money on the virtual paper trading platform.